Kryštof Vladimír

Journals

STETKOVA, M., K. GROWKOVA, P. FOJTIK, B. VALCIKOVA, A. VERLANDE, R. JORDA, V. KRYŠTOF, V. HEJRET, P. ALEXIOU, V. ROTREKL, S. ULDRIAN
CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells. Cell Death & Disease. 2020, 11(9), 754, ISSN: 2041-4889, PMID: 32898621,
JORDA, R., S. KRAJČOVIČOVÁ, P. KRÁLOVÁ, M. SOURAL, V. KRYŠTOF
Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome. European Journal of Medicinal Chemistry. 2020, 204, 112636, ISSN: 0223-5234, PMID: 32731189,
SAID, M., W. ELDEHNA, A. NOCENTINI, S. FAHIM, A. BONARDI, A. ELGAZAR, V. KRYŠTOF, D. SOLIMAN, H. ABDEL-AZIZ, P. GRATTERI, S. ABOU-SERI, C. SUPURAN
Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. European Journal of Medicinal Chemistry. 2020, 189(2020), 112019, ISSN: 0223-5234, PMID: 31972394,